CLINICAL_TRIALS
trial_result
· 2012-12-10
Clinical Trial Update: Tiotropium Respimat Pharmacokinetic Study in COPD [Phase 2]
Summary
Phase 2 pharmacokinetic study of Tiotropium Respimat in chronic obstructive pulmonary disease has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 2 | Status: COMPLETED | Results posted: 2012-12-10